» Articles » PMID: 12682019

HIV Reproducibly Establishes a Latent Infection After Acute Infection of T Cells in Vitro

Overview
Journal EMBO J
Date 2003 Apr 19
PMID 12682019
Citations 565
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of latent reservoirs has prevented the eradication of human immunodeficiency virus (HIV) from infected patients successfully treated with anti-retroviral therapy. The mechanism of postintegration latency is poorly understood, partly because of the lack of an in vitro model. We have used an HIV retroviral vector or a full-length HIV genome expressing green fluorescent protein to infect a T lymphocyte cell line in vitro and highly enrich for latently infected cells. HIV latency occurred reproducibly, albeit with low frequency, during an acute infection. Clonal cell lines derived from latent populations showed no detectable basal expression, but could be transcriptionally activated after treatment with phorbol esters or tumor necrosis factor alpha. Direct sequencing of integration sites demonstrated that latent clones frequently contain HIV integrated in or close to alphoid repeat elements in heterochromatin. This is in contrast to a productive infection where integration in or near heterochromatin is disfavored. These observations demonstrate that HIV can reproducibly establish a latent infection as a consequence of integration in or near heterochromatin.

Citing Articles

Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency.

Dorman A, Bendoumou M, Valaitiene A, Wadas J, Ali H, Dutilleul A Nat Commun. 2025; 16(1):2078.

PMID: 40021667 PMC: 11871326. DOI: 10.1038/s41467-025-57290-y.


Activating PKC-ε induces HIV expression with improved tolerability.

Irrinki A, Kaur J, Randhawa B, McFadden R, Snyder C, Truong H PLoS Pathog. 2025; 21(2):e1012874.

PMID: 39913544 PMC: 11801715. DOI: 10.1371/journal.ppat.1012874.


Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV.

Gentry Z, McAteer O, Hamad J, Moran J, Kim J, Marsden M Sci Adv. 2025; 11(4):eads1911.

PMID: 39854456 PMC: 11778240. DOI: 10.1126/sciadv.ads1911.


Reactivation of latent HIV-1 by the glucocorticoid receptor modulator AZD9567.

Fayyaz S, Lotke R, Haussmann I, Petersen M, Muller E, Schwarzer-Sperber H J Virol. 2025; 99(2):e0188624.

PMID: 39817774 PMC: 11853017. DOI: 10.1128/jvi.01886-24.


Development of a latency model for HIV-1 subtype C and the impact of long terminal repeat element genetic variation on latency reversal.

Maikoo S, Palstra R, Dong K, Mahmoudi T, Ndungu T, Madlala P J Virus Erad. 2025; 10(4):100575.

PMID: 39811575 PMC: 11730875. DOI: 10.1016/j.jve.2024.100575.


References
1.
Choo K, Vissel B, Nagy A, Earle E, Kalitsis P . A survey of the genomic distribution of alpha satellite DNA on all the human chromosomes, and derivation of a new consensus sequence. Nucleic Acids Res. 1991; 19(6):1179-82. PMC: 333840. DOI: 10.1093/nar/19.6.1179. View

2.
Chun T, Fauci A . Latent reservoirs of HIV: obstacles to the eradication of virus. Proc Natl Acad Sci U S A. 1999; 96(20):10958-61. PMC: 34225. DOI: 10.1073/pnas.96.20.10958. View

3.
Poli G, Fauci A . Cytokine modulation of HIV expression. Semin Immunol. 1993; 5(3):165-73. DOI: 10.1006/smim.1993.1020. View

4.
Antoni B, Rabson A, Kinter A, Bodkin M, Poli G . NF-kappa B-dependent and -independent pathways of HIV activation in a chronically infected T cell line. Virology. 1994; 202(2):684-94. DOI: 10.1006/viro.1994.1390. View

5.
Tartof K . Position effect variegation in yeast. Bioessays. 1994; 16(10):713-4. DOI: 10.1002/bies.950161004. View